Next Steps Programs- Melanoma Biomarker Development

The intent of this funding strategy is to help advance translation of discoveries into the clinic by supporting:

1) needed preclinical resources and tools for the research community to identify and begin to develop new therapies and

2) infrastructure to analyze and build large datasets to identify better diagnostic and prognostic biomarkers. 

The goal of this Next Step RFA Melanoma Biomarker Development is to provide seed funding to support early research efforts to ultimately identify and/or validate diagnostic, prognostic, or predictive biomarkers or technologies for melanoma detection, treatment, and management of disease. This funding mechanism is intended to lead to well-developed hypothesis-driven research proposals with enough preliminary data for future grant submission to MRA and other funding sources.

Funding: $150,000 total 
Duration: 1-2 years 

Research Authority due date: 4.7.24